PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11198361-0	2001	Effect of sodium arsenite on iNOS expression and vascular hyporeactivity associated with cecal ligation and puncture in the rat.	sodium arsenite	10-25	nitric oxide synthase 2	Rattus norvegicus	29-33	
11198361-6	2001	Pretreatment of the rats with SA resulted in reversal of CLP-induced vascular hyporeactivity in vivo and ex vivo, and inhibition of iNOS expression after 22 h. SA pretreatment improved 7-day survival after CLP from 18.2% to 70% (P < 0.005).	sodium arsenite	160-162	nitric oxide synthase 2	Rattus norvegicus	132-136	
34006163-0	2021	Ameliorative role of inducible nitric oxide synthase inhibitors against sodium arsenite-induced renal and hepatic dysfunction in rats.	sodium arsenite	72-87	nitric oxide synthase 2	Rattus norvegicus	21-52	
34006163-2	2021	The present study explored the role of inducible nitric oxide synthase (iNOS) inhibitors against sodium arsenite-induced renal and hepatic dysfunction in rats.	sodium arsenite	97-112	nitric oxide synthase 2	Rattus norvegicus	39-70	
34006163-2	2021	The present study explored the role of inducible nitric oxide synthase (iNOS) inhibitors against sodium arsenite-induced renal and hepatic dysfunction in rats.	sodium arsenite	97-112	nitric oxide synthase 2	Rattus norvegicus	72-76	
34006163-13	2021	Hence, it is concluded that iNOS inhibitors attenuate sodium arsenite-induced renal and hepatic dysfunction in rats.	sodium arsenite	54-69	nitric oxide synthase 2	Rattus norvegicus	28-32	
7729015-4	1995	Treatment of RASMCs with hemin and sodium arsenite, which are inducers of HO-1, stimulated RASMC cGMP without stimulating nitrite release or inducible NO synthase expression, and the induced elevations of cGMP were not inhibited by the NO synthase inhibitor NG-methyl-L-arginine.	sodium arsenite	35-50	nitric oxide synthase 2	Rattus norvegicus	141-162